Advertisement

Related Videos

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Opportunities to Optimize Cancer Policies Panel Discussion

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

Advertisement

Advertisement




Dec
03
Today In Oncology
Nivolumab and Ipilimumab in Advanced dMMR/MSI-H Noncolorectal Cancers
FDA Grants Traditional Approval to Pirtobrutinib for CLL/SLL
Lung Cancer Deaths Prevented and Life-Years Gained From Lung Cancer Screening
AYA Cancers Survival for Metastatic Recurrence Worse Than De Novo Metastatic Disease
Survey Finds Global Embrace of Integrative Cancer Care
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo